A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the management of nonhealing diabetic foot ulcers.
This study follows a rescue design: patients in the SOC arm who fail to heal during the CAMPX Prospective Multicenter Randomized Controlled Clinical Trial will enter the Rescue trial and receive the study product. Patients enrolled in this trial must still meet medical necessity criteria for cellular, acellular, matrix-like, products (CAMPs) recently published by the Medicare Administrative Contractor's (MAC) in their local coverage determinations (LCD).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Application of XWRAP + standard of care for up to 12 weeks.
Royal Research
Hollywood, Florida, United States
RECRUITINGWound Closure
The percentage of target ulcers achieving complete wound closure in 12 weeks.
Time frame: 1-12 Weeks
Time to Closure
Time to closure for the target ulcer.
Time frame: 1-12 weeks
Wound Area Reduction
Percentage wound area reduction from TV-1 to TV-13 measured weekly with digital photographic planimetry, using imaging device, and physical examination.
Time frame: 1-12 weeks
Adverse Events
The number of product- or procedure- related adverse events.
Time frame: 1-12 Weeks
Wound Quality of Life
Change in quality-of-Life based on the Wound Quality of Life Questionarie \[Time Frame: TV-1, TV-4, TV-8, TV-12 / Final Visit\].
Time frame: 1-12 weeks
Forgotten Wound Score
Change in quality-of-Life based on the Forgotten Wound Score questionaire \[Time Frame: TV-1, TV-4, TV-8, TV-12 / Final Visit\]
Time frame: 1-12 weeks
Pain, Enjoyment of Life, and General Activity Scale
Change in pain in the target ulcer assessed using the PEG scale \[Time Frame: TV-1 to TV-13\].
Time frame: 1-12 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.